Summary
Johnson & Johnson (JNJ) filed an 8-K on May 1, 2017, detailing the outcomes of its annual shareholder meeting held on April 27, 2017. The meeting saw the overwhelming re-election of all 10 director nominees and robust approval for the company's executive compensation practices and long-term incentive plan. Shareholders also ratified PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2017. Notably, shareholders voted against a proposal for an independent board chairman. In a separate but significant announcement accompanying the meeting results, JNJ's Board of Directors declared a 5.0% increase in its quarterly dividend, raising it from $0.80 to $0.84 per share, signaling continued confidence in the company's financial health and commitment to returning value to shareholders.
Key Highlights
- 1All 10 Director nominees were re-elected by shareholders with substantial "For" votes.
- 2Shareholders approved, on an advisory basis, an annual vote on executive officer compensation.
- 3Executive compensation and the company's compensation philosophy received strong advisory approval.
- 4The material terms of the 2012 Long-Term Incentive Plan were re-approved by shareholders.
- 5PricewaterhouseCoopers LLP was ratified as the independent registered public accounting firm for fiscal year 2017.
- 6A shareholder proposal to have an independent board chairman was not approved.
- 7The Board of Directors declared a 5.0% increase in the quarterly dividend, from $0.80 to $0.84 per share.